v3.26.1
Business Combination - Schedule of Identifiable Intangible Assets Acquired (Details) - Avadel Pharmaceuticals Plc
$ in Thousands
Feb. 12, 2026
USD ($)
Business Combination [Line Items]  
LUMRYZ $ 1,768,600
In-process research and development 26,300
Total identifiable intangible assets $ 1,794,900